492 related articles for article (PubMed ID: 15388993)
21. [DNA repair defect in xeroderma pigmentosum].
Tanaka K
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):473-80. PubMed ID: 2650628
[TBL] [Abstract][Full Text] [Related]
22. Xeroderma pigmentosum and the role of DNA repair in oncogenesis.
Giannelli F
Bull Cancer; 1978; 65(3):323-34. PubMed ID: 719184
[TBL] [Abstract][Full Text] [Related]
23. Functional lentiviral vectors for xeroderma pigmentosum gene therapy.
Marchetto MC; Correa RG; Menck CF; Muotri AR
J Biotechnol; 2006 Dec; 126(4):424-30. PubMed ID: 16857285
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of matrix metalloproteinase 1 in dermal fibroblasts from DNA repair-deficient/cancer-prone xeroderma pigmentosum group C patients.
Fréchet M; Warrick E; Vioux C; Chevallier O; Spatz A; Benhamou S; Sarasin A; Bernerd F; Magnaldo T
Oncogene; 2008 Sep; 27(39):5223-32. PubMed ID: 18469853
[TBL] [Abstract][Full Text] [Related]
25. High incidence of ultraviolet-B-or chemical-carcinogen-induced skin tumours in mice lacking the xeroderma pigmentosum group A gene.
Nakane H; Takeuchi S; Yuba S; Saijo M; Nakatsu Y; Murai H; Nakatsuru Y; Ishikawa T; Hirota S; Kitamura Y
Nature; 1995 Sep; 377(6545):165-8. PubMed ID: 7675085
[TBL] [Abstract][Full Text] [Related]
26. Complementation of the DNA repair deficiency in human xeroderma pigmentosum group a and C cells by recombinant adenovirus-mediated gene transfer.
Muotri AR; Marchetto MC; Zerbini LF; Libermann TA; Ventura AM; Sarasin A; Menck CF
Hum Gene Ther; 2002 Oct; 13(15):1833-44. PubMed ID: 12396616
[TBL] [Abstract][Full Text] [Related]
27. Common pathways for ultraviolet skin carcinogenesis in the repair and replication defective groups of xeroderma pigmentosum.
Cleaver JE
J Dermatol Sci; 2000 May; 23(1):1-11. PubMed ID: 10699759
[TBL] [Abstract][Full Text] [Related]
28. DNA damage and gene therapy of xeroderma pigmentosum, a human DNA repair-deficient disease.
Dupuy A; Sarasin A
Mutat Res; 2015 Jun; 776():2-8. PubMed ID: 26255934
[TBL] [Abstract][Full Text] [Related]
29. Restoring DNA repair capacity of cells from three distinct diseases by XPD gene-recombinant adenovirus.
Armelini MG; Muotri AR; Marchetto MC; de Lima-Bessa KM; Sarasin A; Menck CF
Cancer Gene Ther; 2005 Apr; 12(4):389-96. PubMed ID: 15650764
[TBL] [Abstract][Full Text] [Related]
30. Requirement for functional DNA polymerase eta in genome-wide repair of UV-induced DNA damage during S phase.
Auclair Y; Rouget R; Belisle JM; Costantino S; Drobetsky EA
DNA Repair (Amst); 2010 Jul; 9(7):754-64. PubMed ID: 20457011
[TBL] [Abstract][Full Text] [Related]
31. Multiple involvement of nucleotide excision repair enzymes: clinical manifestations of molecular intricacies.
Jaspers NG
Cytokines Mol Ther; 1996 Jun; 2(2):115-9. PubMed ID: 9384696
[TBL] [Abstract][Full Text] [Related]
32. Mouse model for the DNA repair/basal transcription disorder trichothiodystrophy reveals cancer predisposition.
de Boer J; van Steeg H; Berg RJ; Garssen J; de Wit J; van Oostrum CT; Beems RB; van der Horst GT; van Kreijl CF; de Gruijl FR; Bootsma D; Hoeijmakers JH; Weeda G
Cancer Res; 1999 Jul; 59(14):3489-94. PubMed ID: 10416615
[TBL] [Abstract][Full Text] [Related]
33. Xeroderma pigmentosum group E and DDB2, a smaller subunit of damage-specific DNA binding protein: proposed classification of xeroderma pigmentosum, Cockayne syndrome, and ultraviolet-sensitive syndrome.
Itoh T
J Dermatol Sci; 2006 Feb; 41(2):87-96. PubMed ID: 16325378
[TBL] [Abstract][Full Text] [Related]
34. Understanding Xeroderma Pigmentosum Complementation Groups Using Gene Expression Profiling after UV-Light Exposure.
Bowden NA; Beveridge NJ; Ashton KA; Baines KJ; Scott RJ
Int J Mol Sci; 2015 Jul; 16(7):15985-96. PubMed ID: 26184184
[TBL] [Abstract][Full Text] [Related]
35. Functional retroviral vector for gene therapy of xeroderma pigmentosum group D patients.
Carreau M; Quilliet X; Eveno E; Salvetti A; Danos O; Heard JM; Mezzina M; Sarasin A
Hum Gene Ther; 1995 Oct; 6(10):1307-15. PubMed ID: 8590735
[TBL] [Abstract][Full Text] [Related]
36. Report of three sisters with XP-E, a rare xeroderma pigmentosum complementation group.
Fischer E; Schnyder UW; Jung EG
Photodermatol; 1984 Oct; 1(5):232-6. PubMed ID: 6531300
[TBL] [Abstract][Full Text] [Related]
37. Exploring DNA damage responses in human cells with recombinant adenoviral vectors.
Armelini MG; Lima-Bessa KM; Marchetto MC; Muotri AR; Chiganças V; Leite RA; Carvalho H; Menck CF
Hum Exp Toxicol; 2007 Nov; 26(11):899-906. PubMed ID: 18042584
[TBL] [Abstract][Full Text] [Related]
38. The role of UV induced lesions in skin carcinogenesis: an overview of oncogene and tumor suppressor gene modifications in xeroderma pigmentosum skin tumors.
Daya-Grosjean L; Sarasin A
Mutat Res; 2005 Apr; 571(1-2):43-56. PubMed ID: 15748637
[TBL] [Abstract][Full Text] [Related]
39. Association between DNA repair-deficiency and high level of p53 mutations in melanoma of Xeroderma pigmentosum.
Spatz A; Giglia-Mari G; Benhamou S; Sarasin A
Cancer Res; 2001 Mar; 61(6):2480-6. PubMed ID: 11289118
[TBL] [Abstract][Full Text] [Related]
40. UV damage causes uncontrolled DNA breakage in cells from patients with combined features of XP-D and Cockayne syndrome.
Berneburg M; Lowe JE; Nardo T; Araújo S; Fousteri MI; Green MH; Krutmann J; Wood RD; Stefanini M; Lehmann AR
EMBO J; 2000 Mar; 19(5):1157-66. PubMed ID: 10698956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
